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Abstract 
PAIN OUT is a European Commission-funded project aiming at improving postoperative pain 
(POP) management. It combines a registry that can be useful for quality improvement (QI)  
and research using treatment and patient-reported outcome measures. Core of the project is 
a patient questionnaire - the International Pain Outcomes questionnaire (IPO) that comprises 
key patient level outcomes of POP management including pain intensity, physical and 
emotional functional interference, side effects, and perceptions of care. Its psychometric 
quality after translation and adaptation to European patients is the subject of this validation 
study. The questionnaire was administered to 9,727 patients in 10 languages in eight 
European countries and Israel. Construct validity was assessed using factor analysis (FA). 
Discriminant validity assessment used U-tests to detect mean group differences between two 
surgical disciplines. Internal consistency reliability was calculated as Cronbach‟s alpha. FA 
resulted in a three factor structure explaining 53.6% of variance. Cronbach‟s alpha at overall 
scale level was high (0.86), and for the 3 subscales was low, moderate, or high (range 0.53 
to 0.89).  Significant mean group differences between general and orthopaedic surgery 
patients confirmed discriminant validity. The psychometric quality of the IPO can be regarded 
as satisfactory.  
Perspective: The IPO questionnaire provides an instrument for POP assessment and 
improvement of quality of care, which demonstrated good psychometric quality when 
translated to a variety of languages in a large European and Israeli patient population. This 
measure provides the basis for the first comprehensive POP registry in Europe and other 
countries.  
Key words: pain measurement, postoperative pain, pain registry, quality improvement, PAIN 
OUT
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Introduction 
The quality of postoperative pain management is an issue of ongoing debate1,20,4,11. The 
Global Year against Acute Pain initiated by the International Association for the Study of Pain          
(IASP) in 2010 demonstrated the demand for action in this area. Registries are proven tools 
to improve knowledge and quality of clinical care in many fields of medicine24,31,14. According 
to Glicklich & Dryer, “a patient registry is an organized system that uses observational study 
methods to collect uniform data (clinical and other) to evaluate specified outcomes for a 
population defined by a particular disease, condition, or exposure and that serves a 
predetermined scientific, clinical, or policy purpose(s)”14.Registries are able to provide a 
picture of medical treatment strategies applied and related patient outcomes closer to clinical 
routine than randomized controlled trials (RCTs) do, since they include heterogeneous 
patients, often elderly and those burdened with co-morbidities. Registries offer the possibility 
for continuous benchmarking of treatment outcomes, evaluation of interventions, and can 
facilitate best practice25. Although several registry initiatives in the field of pain exist on 
national level25,27, so far, there is no comprehensive, multi-national registry in pain medicine.  
The European Commission funded PAIN OUT project combines a quality improvement (QI) 
approach with a registry and development of a clinical decision support system to advance 
the quality of acute postoperative pain management and research in this field in Europe37. 
Feasibility of this approach has been pilot tested and is reported elsewhere41. Based on the 
registry data, two tools are provided to clinicians to facilitate pain management in 
participating hospitals: a patient outcomes survey benchmark module providing online 
feedback for internal and external benchmarking; and a clinical decision support system 
based on case based reasoning. A third tool is an electronic knowledge library, providing 
easy access to existing guidelines in acute pain.  
PAIN OUT is being developed and tested by a total of 17 research and clinical partners 
receiving EU funding, out of which 11 clinical sites in 9 countries (France; Germany; Italy; 
Israel; Romania; Spain; Sweden; Switzerland; United Kingdom) carry out data collection.  
International recognition in an early stage of the project led to an expansion of PAIN OUT to 
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the US and to a number of clinical sites worldwide (a complete list of PAIN OUT partners is 
provided online as Supplemental Information 1). Patient-reported outcomes of pain 
management are complemented with detailed audits of medical records that collect 
demographics and perioperative pain treatment information (process questionnaire). Both 
elements combine to form the registry. This paper reports on the European and Israeli 
patient outcomes data from cross-cultural translated patient surveys in the PAIN OUT 
Registry.  
In 2010, the 17 EU funded PAIN OUT members undertook a Delphi process to determine the 
items to include in the patient outcome questionnaire. The Delphi process resulted in a list of 
items closely resembling those in the recently revised American Pain Society Patient 
Outcomes questionnaire (APS-POQ-R)17. Consequently, the group decided to use the APS-
POQ-R that has established preliminary psychometrics as a starting point for the project‟s 
patient outcomes questionnaire. Several additional questions were added, as a basis for 
further testing of categorical scaling and adaptation of patient reported outcomes to the 
postoperative setting in a European population. The APS-POQ has an almost 20-year history 
of iterative improvement and can be regarded as an instrument with satisfactory 
psychometric properties33,15,16,10. The latest version of the APS questionnaire (the APS-POQ-
R) was revised and validated in 201017 and covers five aspects of outcome measurement in 
acute pain: pain severity, interference with function, affective experience, side effects, and 
perceptions of care. It was adapted to the postoperative setting and translated into all 
languages required by the PAIN OUT project following a strict forward and backward 
procedure. An interdisciplinary group of experts (nurses, physicians, a psychologist, a 
statistician, and a computer scientist) carried out the present validation study.  Therefore the 
purpose of this paper is to report on the psychometric quality of the questionnaire after its  
translation and adaptation to the requirements of the postoperative setting. 
 
Material and Methods  
Overview 
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In summary, the validation procedure was carried out in two phases (see figure 1). In phase 
one, the 23 question APS-POQ-R was supplemented with five additional items proposed by 
experts in the PAIN OUT group as possible alternative wording and categorical scaling (see 
below for details). A total of 5,134 patients from 1 to 3 sites in each of the 9 countries 
completed the resulting first version of the instrument between February and December 2010 
that from now on is termed the International Pain Outcomes questionnaire (IPO). Results 
from this first phase of data collection are presented in Supplemental Information 2. 
Preliminary psychometric analysis and feedback received from patients and research 
assistants, resulted in further adaptation of the questionnaire. In phase two, from February 
until October 2011, the modified questionnaire was administered to a new group of 4,590 
patients, and its psychometric properties were again assessed. Presentation of results 
focuses on this second assessment. Details of the two phases are described below.  
(Insert figure 1 here) 
 
Material 
Patient selection & eligibility: The study protocol was reviewed by the Institutional Review 
Board or Ethics Committee at all sites. All study procedures were in accordance and 
compliance with the regulations and the institutions‟ policies and guidelines for protection of 
human subjects. Eligible patients were identified from inpatient orthopedic and general 
surgery census lists. Where research assistants did not have sufficient capacity to approach 
all eligible patients, PAIN OUT Standard Operating Procedures provided clear guidance on 
how to achieve a random selection. Surgical patients were approached in their hospital room 
on postoperative day number one, and invited to participate by a Research Assistant (RA) 
using a consent form as determined by local Institutional Review Boards. Patients had to be 
of consenting age (varying in the European countries from 16-18 years) or over; able to 
communicate; and not cognitively impaired. All patient outcome data were collected on 
postoperative day 1, when patients were back on the ward for at least 6 hours.  
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Data acquisition: Each of the 11 EU funded clinical sites contributing to data collection (see 
also online Supplemental Information 1) appointed a RA responsible for data collection. A 
training workshop was held to familiarize the RAs with the requirements of data collection. A 
detailed standard operating procedures manual or data dictionary was available in written 
form. It was intended that patients should complete the IPO independently using paper and 
pencil. Only in defined, exceptional cases (e.g. reading glasses not available; arm in a cast; 
patient too weak to fill it in independently) were interviews by the RAs allowed. The RAs also 
filled in a supplemental assessment form for the first 300 patients at their site, pointing out 
any difficulties and ambiguities with items that were encountered. After the end of phase 1, a 
feedback meeting with RAs was held to evaluate experiences with the IPO.  
Questionnaire: 
The APS-POQ-R covers the following areas: pain severity (4 items), pain interference with 
physical function (4 items) and affect (4 items), adverse effects (4 items), and perceptions of 
care (6 items) plus an item on use of non-pharmacological treatments deemed unreliable if 
obtained from medical records. The five supplemental items introduced by the PAIN OUT 
expert group in phase 1 of the data collection addressed categories of time spent in severe 
pain; patient‟s wish for more pain treatment than received; patient‟s wish for less pain 
treatment than received; sleep quality; and pre-operative chronic pain conditions. Taking into 
account the results of psychometric analysis of phase 1 data and feedback from patients and 
RAs, the expert group decided on a final set of items for phase 2, as presented in 
Supplemental Information 3. This final version of the IPO was re-administered and 
reassessed in a new prospective population of patients from the same clinical sites as in 
phase 1. 
 
Methods 
Translation procedure: The translation of the questionnaire from English was carried out 
according to international scientific standards40,3. A translation agency working with native 
speakers for each language conducted the work. The questionnaire was translated by a 
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 8 
professional translator and by a clinician into each of the languages required by the project 
(Arabic, French, German, Italian, Hebrew, Romanian, Russian, Spanish, and Swedish). The 
agency combined these two versions into one and back-translated the synthesized version 
into English. These back-translations were evaluated, deviations from the original English 
questionnaire were discussed, and a beta version was built. This beta version was piloted 
with 50 patients per language, difficulties in understanding and ambiguities were documented 
and the items concerned were modified where necessary. 
Psychometric analysis: Descriptive statistics (means and standard deviations or frequencies, 
as applicable) were calculated for all items. Construct validity was assessed by exploratory 
factor analysis using principal component analysis with promax rotation29. Given skewed 
distributions, the appropriateness of this approach was confirmed using the Kaiser-Meyer-
Olkin-(KMO) and Bartlett tests. Reliability testing used Cronbach‟s alpha for internal 
consistency of the overall questionnaire and of the subscales identified in factor analysis6,26. 
In addition, discriminant validity was assessed using the contrasting groups approach. 
Specifically, we used Mann-Whitney U tests and Chi-squared tests to assess whether the 
questionnaire items would distinguish between general surgery and orthopaedic surgery 
patient-outcomes. T-tests were run in parallel for comparison purposes. All analyses were 
carried out using STATA/MP 10.1 and 11.0 (StataCorp, College Station, Texas, USA) and 
SPSS 18.0 (SPSS Inc., Chicago, Illinois, USA). 
 
Results 
Patient accountability and characteristics 
In phases 1 and 2, the patient outcome questionnaire was completed by 5,134 and 4,590 
patients, respectively. Figure 2 shows the number of patients per clinical site. Results for the 
phase 1 validation process are shown in Supplemental Information 2.  
(Insert figure 2 here) 
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Of the 6,795 patients screened in phase two, 32.5% of patients were excluded. The number 
of patients (%) excluded according to the different criteria can be found in table 1. The 
exclusion reasons do not add up to 32.5%, since the categories are not mutually exclusive.  
The proportion of female patients was 50.0%. The mean age was 54.4 years ± 17.1; range 
15-103. The language versions used are displayed in table 2. Patients were admitted to 
general surgery departments in 42.1% and in orthopedic departments in 51.8% (see also 
table 2). 
 
Descriptive analysis of patient outcome questionnaire items  
Numeric rating scale (NRS) items are provided in table 3a, expressed as mean values and 
standard deviation. The observed range of scores (minimum and maximum) for all NRS 
items was 0 to 10. Means of NRS items were similar between the two phases of data 
collection. Frequencies for items with binary or categorical answer format are provided in 
table 3b. Occurrence of missing values was below 3% for most items. Two items using 
percentage scales (time spent in severe pain; pain relief achieved) and two covering 
perception of care topics (participation in pain treatment decisions; satisfaction) had slightly 
higher proportions of missing values ranging from 2.7-9.2%. 
Regarding preoperative chronic pain, 49.3% of patients suffered from persistent pain before 
surgery, its intensity being 6.4 NRS points. In 59.9% of cases the persistent pain was at the 
site of surgery, in 10.8% was elsewhere, and in 29.3% was present both at the site of 
surgery and in other body areas. A total of 16.9% of patients would have wished more pain 
treatment than they received.  
 
Adaptation of questionnaire  
The phase 1 questionnaire showed favorable psychometric properties overall (see 
Supplemental Information 2), which supports previous work by the APS17. Further 
adaptation leading to phase 2 aimed both at shortening the instrument without loss of 
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substantial information and at adapting it to the needs of the European patient population. 
The following changes were made:  
1. The two pain interference items on „falling asleep‟ and „staying asleep‟ were 
combined into a single new item asking whether „pain interfered with or prevented 
you from sleeping‟, since the two original items had a high inter-item-correlation of 
r=.84, the highest of the whole correlation matrix.  
2. A new item asking whether „pain interfered with or prevented you from breathing 
deeply or coughing‟ was introduced, as this was regarded by the expert group as 
being of high clinical importance, especially for patients undergoing general surgery.  
3. A filter question was introduced before the item on „interference with activities out of 
bed‟ to separate out those patients who had not yet been out of bed at the time of 
being surveyed. Without such a filter, a high rate of missing answers (17.5%) was 
noted with the first version of the questionnaire.  
4. Two of the four emotional impairment items („frightened‟ and „depressed‟) were 
removed. Both had a high inter-item correlation (r=.67 and r.=65, respectively) with 
the „anxious‟ item. Apart from high inter-item correlations there were lingual and 
cultural reasons for taking out the two items „depressed‟ and „frightened‟. In many 
languages both translators and patients had difficulties in telling the difference 
between „frightened‟ and „anxious‟. Since „anxious‟ was clearer to most patients we 
decided to keep „anxious‟. Another reason was that many patients in various 
countries reacted irritated on the item „depressed‟.  
5. The item „How often did a nurse or doctor encourage you to use non-medicine 
methods?‟ was removed, since in 76.5% of cases the answer was „never‟. In addition, 
in some countries this item was regarded as difficult to understand.  
6. Of the five items added to APS-POQ-R questionnaire, two were kept. 'Would you 
have liked more pain treatment than you received? (yes/no)' increased Cronbach‟s 
alpha of the sub-scale „perceptions of care‟ from 0.55 to 0.61. The item and sub-items 
addressing chronic pain were kept because of their clinical relevance and because 
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medical record-based information on the presence of chronic pain (as collected on 
the phase 1 process questionnaire) proved to not be sufficiently reliable. Of the items 
not included in the phase 2 questionnaire, „would you have liked less pain treatment 
than you received?‟ (yes/no) was only answered 'yes' by 3.8 % of patients. „Did you 
wake up due to pain?‟ slightly decreased Cronbach‟s alpha for the „pain intensity and 
interference‟ sub-scale when replacing „interference with staying asleep‟. Finally, the 
original APS-POQ-R item „percentage of time spent in severe pain‟ was not replaced 
by the alternative using a categorical answer format due to marginal impact on 
internal consistency results. 
 
Results after adaptation of questionnaire 
Exploratory factor analysis 
The appropriateness of using exploratory factor analysis on the phase 2 set of 16 NRS items 
to assess construct validity was confirmed by the results of the KMO test (0.901) and the 
Bartlett test (p < 0.001). Principal component analysis with promax rotation was used. 
Pairwise exclusion of missing values resulted in case numbers ranging from 3,186 to 4,585. 
The factor analysis generated a three factor solution (Eigen value >1), explaining a total 
variance of 53.8 %. The factor loadings per item are displayed in table 4. The group of pain 
intensity and interference items forms one factor together with the two remaining „affective 
impairment‟ items, explaining 36.0 % of variance. The factors „adverse effects‟ and 
„perceptions of care‟, explaining 10.3% and 7.5% of variance, remained unchanged.  
Internal consistency reliability 
Cronbach‟s alpha and related statistics is displayed in table 5. Overall Cronbach‟s alpha was 
0.86. As in phase 1, the subscale „pain intensity and interference (physical and emotional)‟ 
achieved the best Cronbach‟s alpha (r=.89), followed by „adverse effects‟ (r=.67) and 
„perceptions of care‟ (r=.55).  
Discriminant validity 
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For all NRS items but one, a significant difference between the general surgery and 
orthopedic patient groups was observed (see table 6). Exception was „nausea‟ with an 
almost equal mean in orthopedic and general surgery patients (1.67 and 1.75 respectively). 
All pain intensity items, both items on affective impairment and three interference items were 
significantly increased in orthopedic patients. The new item on „pain interference with 
breathing/coughing‟ had an increased mean value in general surgery patients. Both adverse 
effects „dizziness‟ and „drowsiness‟ were also increased in general surgery patients, „itching‟ 
was slightly increased in orthopedic patients. As in phase 1, „percentage of pain relief‟ and 
„satisfaction with pain treatment‟ showed significantly higher scores in the patients treated in 
general surgery, while the item „participation in decision making‟ was again increased in 
orthopedic patients.  
 
Discussion 
The PAIN OUT project establishes a registry that can be used for local QI benchmarking or 
larger scale research studies using patient-reported outcome data, demographics, with real-
world perioperative treatment details41. Unlike most registries that contain only medical 
record audit data, PAIN OUT incorporates a self-reported patient questionnaire (IPO), 
comprising key outcome of postoperative pain management including pain intensity, physical 
and emotional functional interference, side effects, and perceptions of care. The 
psychometric quality of the IPO after translation and adaptation to European patients is the 
focus of this validation study. The aim followed in this paper was not to examine differences 
between different language versions, but to test how the IPO performs overall in this 
European population. Reports on the psychometric quality of the instrument for each 
language separately will be published elsewhere as will focused analysis of perioperative 
treatment data obtained from the medical record reviews. To our knowledge this is the first 
study validating a multi-dimensional outcomes questionnaire in a comprehensive, two-step, 
multi-national validation process in the field of postoperative pain. The IPO was applied to a 
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total of 9,727 patients in Europe and Israel. It achieved satisfactory psychometric quality both 
for reliability and for validity. 
Numerous validation studies have previously addressed the translation and adaptation of 
well established instruments like the Brief Pain Inventory (BPI) into one new 
language8,34,35,38,23. The approach taken in this study, to assess reliability and validity of a 
questionnaire for a combination of languages, has been rarely used5. Nevertheless, we 
achieved satisfactory statistical results. However, it may only be valid when the languages 
have a high degree of similarity by belonging to the same language family like it is the case 
here, since most of the languages involved belong to the Indo-European language family. 
This similarity of languages was also a given in the study cited above5.  
The factor analysis conducted on phase 2 data generated a three factor structure 
unlike in phase 1, where four factors resulted (see also Supplemental Information 2 for 
phase 1 data). The two separate factors „pain intensity and interference‟ and „affective 
impairment‟ in phase 1 combined to one composite factor in phase 2, where only 2 affective 
impairment items („anxious‟ and „helpless‟) remained. From the perspective of construct 
validity this combination makes sense. Interference of pain with emotional aspects could be 
regarded as one facet of interference with “function”, in this case emotional functioning. 
Some instruments for pain measurement follow this notion and ask comprehensively for „pain 
interference with mood‟27,19,21,28. Some authors have reported low factor loadings of 
„interference with sleep‟ for their instruments measuring pain interference30,36. However, even 
after combining the two original items on sleep interference („falling asleep‟ and „staying 
asleep‟) into one („interference with sleep‟) in the IPO, this item still has a high factor loading 
of 0.714 in our analysis. The low loading of the item „interference with breathing/coughing‟ 
(0.43) can be explained by left-skewed distribution and its floor effect for orthopedic patients 
(median 0, m=1.11), whereas in general surgery the values are higher (median 1, m=2.64).  
Overall reliability of the IPO with a Cronbach‟s alpha of 0.86 is satisfactory and in line with 
comparable validation studies17,2,13,39,22,32. The high Cronbach‟s alpha of 0.89 for the subscale 
„pain intensity and pain interference (physical and emotional)‟ confirms the homogeneity of 
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this subscale, even after inclusion of the two items on emotional impairment. Internal 
consistency for the subscale „adverse effects‟ is with 0.67 very close to the APS result, 
whereas the „perceptions of care‟ subscale achieves a lower, questionable Cronbach‟s alpha 
(0.53 vs. 0.70) in our study17. The low values for these subscales have substance matter 
explanations: Their items do not follow the classic notion of measurement of one dimension. 
This is particularly true for the „perceptions of care‟ scale. Nevertheless, all three components 
of this scale convey very important information and are needed in the questionnaire. 
Especially for the subscale „perceptions of care‟ it may however be worth considering 
whether the 3 items concerned should be treated separately instead of combining them into 
a scale. In the case of „adverse events‟, a common scale may make more sense but it should 
be noted that we do not expect these items to be highly correlated as different approaches to 
pain treatment can lead to different patterns of adverse events. 
Substantial differences in pain treatment outcomes in various surgical disciplines are 
documented27,41. The criterion to establish discriminant validity used in this study was 
therefore the outcome difference between the two disciplines general and orthopedic 
surgery. Indeed, the significant outcome differences found in our study between general 
surgery and orthopedic surgery patients confirm discriminant validity of the instrument. Pain 
intensity and pain interference is increased in orthopedic patients. The increased mean score 
for „interference with breathing/coughing‟ in the general surgery patient group is also 
plausible given the surgical sites involved. The increased values in the items „percentage of 
pain relief from all pain treatments combined (medicine and non-medicine)‟ and „satisfaction 
with pain treatment‟ in general surgery patients are well in line with the lower pain intensity 
and functional interference values in this discipline. The increased score for the item 
„Participation in decision making‟ in orthopedic patients cannot be explained easily and may 
mirror differences in provider practices or patient populations in the two surgical disciplines in 
question.  
In contrast to the APS-POQ-R, our questionnaire asks patients about chronic pain before 
surgery. This combination may allow gaining new insights into the interaction between 
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chronic and acute pain with regard to treatment responses. To this end, PAIN OUT is 
collaborating with the European observational study on Chronic Post Surgical Pain 
(euCPSP) project, supported by the European Society of Anaesthesiology. Thus, PAIN OUT 
is providing means to link acute pain data in the registry with data on chronification collected 
by euCPSP12. 
Limitations  
A number of limitations apply to this study. First, not all factors potentially influencing 
patients‟ pain outcomes could be collected, which may limit the range of additional research 
questions that can be addressed with the currently collected data. Specifically, we did not 
collect data about socioeconomic status and level of education, though there is evidence 
indicating that both are influential in patient‟s assessment of pain9,18,7. PAIN OUT records 
ethnicity of patients in the demographics section of the questionnaire in countries where this 
is recorded, yet this task remains a challenge. Interestingly, cultural differences in 
approaching these issues and deviating attitudes about political correctness throughout 
Europe, constituting themselves part of ethnical differences, make it difficult to obtain 
consistent data on patient ethnicity. 
The validity of the IPO can only be assumed for the patient population contributing to this 
study, i.e. adults with normal cognitive functioning. Children, cognitively impaired patients, 
and other languages are excluded.  
It would have been interesting to compare outcomes between the different countries involved 
in the project. However, apart from one country with three clinical sites for data collection, all 
other countries contributed with data from only one clinical site. At this stage of the project 
comparisons between countries have to be treated with caution, since differences found may 
well be due to site specific effects rather than language or country related differences. So far, 
we know hardly anything about outcome differences in various countries. At the current 
stage, outcome differences between countries would be too weak criteria for discriminant 
validity and would therefore be no useful approach in a validation study. However, in-depth 
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analysis of country specific outcome differences are currently carried out and a separate 
publication addressing this topic is in preparation.   
In the setting of postoperative pain it might be worthwhile to focus further research on a 
better adaptation of pain interference items on the surgical discipline in question. E.g. for 
maxillofacial surgery it could be useful to have patients assessing „pain interference with 
eating/chewing‟.  Further research is underway to examine variations in treatment patterns 
and how these interact with patient outcomes. 
Since this was the first time the IPO was used in a larger patient population further studies 
need to cross-validate and confirm the dimensionality, reliability, and validity of the IPO.   
Conclusions 
The rationale for developing and testing the IPO was to create a standard, uniform 
methodology for assessing patient reported outcomes when creating the PAIN OUT registry 
for a primary non-English European population. The questionnaire will be used in Europe 
and worldwide. It is piloted already in clinical sites in South-East Asia, Australia, Africa, and 
the US, which participate in the international branch of the project. The validation process for 
the non-European countries is currently ongoing. Using this standard methodology will allow 
for better communication between clinicians and researchers, facilitating QI and large scale 
epidemiologic studies that have not been possible to conduct before. 
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Figure legends 
 
Figure 1: Validation process flowchart 
 
Figure 2: Case numbers for phase 1 and 2 per clinical site 
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Table 1: Number of patients (%) excluded. 
Exclusion criteria N=6,795 
Not being in the ward for at least 6 
hours on post-operative day 1 
7.1% 
Patient under consenting age 1.3% 
Patient is not available/not on the 
ward or discharged 
10.1% 
Patient did not give assent 7.1% 
Patient is too ill 3.6% 
Patient is asleep 9.5% 
Problems in understanding/ 
language problems 
2.4% 
Patient is cognitively impaired 1.2% 
Other reasons 2.7% 
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Table 2: Demographics  
 
 Demographic data 
Characteristics N Value 
Female gender; frequency (%) 4,573 2,287 (50.0) 
Age; mean years ± SD; range 4,552
2
 54.4±17.1; 15-103 
Language version used; frequency (%) 4,146  
 German  1,338 (32.3) 
 Italian  490 (11.8) 
 Spanish  330 (8.0) 
 French  489 (11.8) 
 Romanian  476 (11.5) 
 Swedish  450 (10.9) 
 Hebrew  349 (8.4) 
 English  197 (4.8) 
            Other
1
  27 (0.6) 
Ward specialty; frequency (%) 4,590  
             General surgery  1,934 (42.1) 
 Orthopedics  2,538 (55.3) 
 Other, unknown or missing  118 (2.6) 
                                                 
1
 Translations into additional languages (e.g. Russian and Arabic) representing relevant minorities in the some of 
the participating countries are also available.  
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Table 3a: Frequencies, means, and standard deviations for NRS items.  
 
NRS Items N Mean SD 
Least pain in 24 hours 4,554 1.77 1.87 
Worst pain in 24 hours 4,576 5.16 2.83 
Percentage of time in severe pain
2
 4,468 2.64 2.60 
Pain interference with activities in bed 4,458 4.28 3.17 
Pain interference with activities out of bed 3,186
3
 3.36 2.88 
Pain interference with breathing/coughing 4,471 1.78 2.67 
Pain interference with sleep 4,482 2.84 3.07 
Emotional impairment due to pain: anxious 4,513 2.14 2.74 
Emotional impairment due to pain: helpless 4,460 2.26 3.04 
Adverse effects: nausea 4,528 1.70 2.78 
Adverse effects: drowsiness 4,508 2.70 2.98 
Adverse effects: itching 4,486 0.54 1.62 
Adverse effects: dizziness 4,511 1.71 2.50 
Percentage of pain relief from all treatments 
combined 
4,255 6.92 2.70 
Participation in decision making 4,169 5.88 3.95 
Satisfaction with pain treatment 4,333 8.20 2.17 
Intensity of persistent pain before surgery 2,313 6.25 2.36 
 
                                                 
2
 Percentage scales were transferred to a 0 – 10 scale to facilitate comparison 
3
 This N is lower because the questionnaire contains a complementary items asking whether patients had been 
out of bed already. Only if this question was answered with ‘yes’ the item on pain interference with activities out 
of bed was scored.  
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Table 3b: Frequencies and percentages for binary and categorical items 
 
Binary items (% ‘yes’ answers) N %  
Information about pain treatment options 4,513 64.72 
Use of non-medicine methods for pain relief 4,531 43.77 
Wish for more pain treatment 4,519 16.93 
Persistent painful condition before surgery 4,539 52.63 
Categorical items (% per category) N %  
Location of persistent pain before surgery 2,330 100.00 
 site of surgery 62.19 
 elsewhere 9.10 
 both  28.71 
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 Table 4: Rotated component matrix of factor loadings for NRS items. 
 
 Components 
1 2 3 
Pain 
intensity and 
interference 
Adverse 
effects 
Perceptions 
of care 
Explained variance (total: 53.58%)  36.00% 10.31% 7.49% 
Worst pain in 24 hours .775. .262. -.204. 
Least pain in 24 hours .722. .184. -.262. 
Percentage of time in severe pain .805. .186. -.280. 
Pain interference with activities in bed .752. .337. -.191. 
Pain interference with breathing or coughing .495. .349. -.125. 
Pain interference with sleep .743. .229. -.211. 
Pain interference with activities out of bed .777. .321. -.195. 
Emotional impairment due to pain: anxious .686. .386. -.171. 
Emotional impairment due to pain: helpless .717. .415. -.172. 
Adverse effects: nausea .271. .736. -.022. 
Adverse effects: drowsiness .289. .772. -.106. 
Adverse effects: itching .209. .448. -.067. 
Adverse effects: dizziness .369. .767. -.049. 
Percentage of pain relief in 24 hours -.489. .029. .608. 
Participation in decision making .001. -.093. .774. 
Satisfaction with pain treatment -.489. -.080. .734. 
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Table 5: Cronbach's alpha and item-to-subscale (item-rest) correlations for the 16 NRS items 
and for the three subscales. 
 
Item N Sign Item-test 
correlation 
Item-rest 
correlation 
Average 
inter-item 
correlation 
alpha 
Worst pain in 24 hours 4576  + 0.71 0.65 0.27* 0.85* 
Least pain in 24 hours 4554  + 0.67 0.60 0.28* 0.85* 
Percentage of time in severe pain 4468  + 0.72 0.66 0.27* 0.85* 
Pain interference with activities in bed 4458  + 0.71 0.65 0.27* 0.85* 
Pain interference with breathing or 
coughing 
4471  + 0.53 0.44 0.29* 0.86* 
Pain interference with sleep 4482  + 0.68 0.61 0.28* 0.85* 
Pain interference with activities out of 
bed 
3186  + 0.72 0.66 0.28* 0.85* 
Emotional impairment due to pain: 
anxious 
4513  + 0.68 0.61 0.28* 0.85* 
Emotional impairment due to pain: 
helpless 
4460  + 0.71 0.64 0.27* 0.85* 
Adverse effects: nausea 4528  + 0.46 0.36 0.30 0.86* 
Adverse effects: drowsiness 4508  + 0.49 0.40 0.29* 0.86* 
Adverse effects: itching 4486  + 0.35 0.25 0.31* 0.87* 
Adverse effects: dizziness 4511  + 0.54 0.45 0.29 0.86* 
Percentage of pain relief in 24 hours 4255  + 0.49 0.40 0.29* 0.86* 
Participation in decision making 4169  + 0.20 0.09 0.32* 0.87* 
Satisfaction with pain treatment 4333  + 0.54 0.45 0.29* 0.86* 
Test scale     0.28      0.86 
Subscales       
„Pain intensity and interference 
(physical and emotional)‟ 
4576 - - - 0.47 0.89 
„Adverse effects‟ 4528 - - - 0.33 0.67 
„Perceptions of care‟ 4333 - - - 0.29 0.55 
* For test scale, if item removed from test scale. 
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Table 6: Significant differences of 16 items for type of surgery (general versus orthopedic 
surgery). 
 
Item N  
General 
surgery 
Mean  
General 
surgery 
Standard 
deviation 
N  
Ortho.
4
 
surgery 
Mean 
Ortho. 
surgery 
Standard 
deviation 
p value 
Mann-
Whitney 
U test* 
Worst pain in 24 
hours 
1,922 4.61 2.91 2,536 5.60 2.69 <0.001 
Least pain in 24 hours 1,917 1.53 1.78 2,520 1.96 1.93 <0.001 
Percentage of time in 
severe pain 
1,883 2.12 2.46 2,467 3.07 2.65 <0.001 
Pain interference with 
activities in bed 
1,878 3.98 3.19 2,463 4.53 3.15 <0.001 
Pain interference with 
breathing or coughing 
1,881 2.64 3.08 2,474 1.11 2.09 <0.001 
Pain interference with 
sleep 
1,882 2.32 3.00 2,486 3.24 3.08 <0.001 
Pain interference with 
activities out of bed 
1,628 2.87 2.86 1,451 3.97 2.84 <0.001 
Emotional impairment 
due to pain: anxious 
1,899 1.97 2.77 2,497 2.28 2.72 <0.001 
Emotional impairment 
due to pain: helpless 
1,864 1.95 2.94 2,479 2.51 3.11 <0.001 
Adverse effects: 
nausea 
1,901 1.75 2.87 2,509 1.67 2.71 0.803 
Adverse effects: 
drowsiness 
1,891 2.99 3.09 2,501 2.51 2.89 <0.001 
Adverse effects: 
itching 
1,876 0.51 1.62 2,494 0.57 1.64 0.009 
Adverse effects: 1,894 1.85 2.63 2,500 1.58 2.38 0.002 
                                                 
4
 Orthopedic surgery 
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dizziness 
Percentage of pain 
relief in 24 hours 
1,763 7.25 2.80 2,377 6.65 2.61 <0.001 
Participation in 
decision making 
1,756 5.20 4.25 2,300 6.33 3.64 <0.001 
Satisfaction with pain 
treatment 
1,811 8.55 2.01 2,404 7.93 2.25 <0.001 
Binary item N  
General 
Surgery 
% ‘yes’  
General 
surgery 
 N  
Ortho. 
surgery 
% ‘yes’  
Ortho. 
surgery 
 p value 
Chi
2
 test 
Information on pain 
treatment options 
received 
1,905 58.8 -- 2,490 68.7 -- <0.001 
Use of non-medicine 
methods for pain relief 
1,909 34.3 -- 2,504 51.2 -- <0.001 
* Results of T-tests run in parallel for comparison purposes were highly consistent with Mann-Whitney U test 
results. 
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Phase 1 validation results 
Exploratory factor analysis 
An exploratory factor analysis was carried out including all 18 NRS items using principal 
component analysis with promax rotation to assess construct validity. Pairwise exclusion of 
missing values was applied and resulted in case numbers ranging from 4,238 to 5,108. The 
results are comprised in table 1. The four resulting factors with an Eigen value >1 achieved a 
total explained variance of 60.78%. All items except one reached very satisfying factor 
loadings >.63. The factor structure is comparable to the results for the APS-POQ-R11 and we 
therefore chose to retain the same naming of these factors as described in this previous 
publication. The first factor, ‘pain intensity and interference’, consists of the three items on 
pain intensity (least pain, worst pain, and time spent in severe pain) and the four items 
addressing pain interference (with activities in bed, with activities out of bed, with falling 
asleep, and with staying asleep). The second factor comprises the four items on emotional 
impairment due to pain (‘anxious’, ‘depressed’, ‘frightened’, and ‘helpless’) and was named 
‘affective impairment’. The four items dealing with side effects (‘nausea’, ‘drowsiness’, 
‘itching’, and ‘dizziness’) load on the third factor ‘adverse effects’. The fourth factor, 
‘perceptions of care’, includes three relatively heterogeneous items ‘pain relief’, ‘participation 
in decisions on pain treatment’, and ‘satisfaction with pain treatment’.  
Internal consistency reliability 
Cronbach’s alpha and related statistics were calculated at item level (see Table 2) for the 18 
NRS items and for the subscales identified in factor analysis (see Table 3). Overall 
Cronbach’s alpha was 0.88. At the subscale level internal consistency was best for ‘pain 
intensity and interference’ (r=.89), followed by ‘affective impairment’ (r=.87) and ‘adverse 
effects’ (r=.67). The ‘perceptions of care’ subscale showed the lowest internal consistency 
(r=.53).  
Discriminant validity 
Tables
Table 4 summarizes to what extent the 18 NRS items differentiated between patients treated 
in general surgery versus in orthopaedic wards based on Mann-Whitney-U tests. All pain 
severity and interference items were significantly increased in patients treated in orthopaedic 
wards. Items ‘percentage of pain relief’ and ‘satisfaction with pain treatment’ were 
significantly decreased, indicating the same direction of association. Average scores were 
also higher in all affective items, although these differences for the items ‘feeling anxious’ 
and ‘feeling frightened’ were not significant. The adverse effect ‘nausea’ was significantly 
higher in the general surgery patient group. The item ‘participation in decision making’ 
showed significantly higher scores in patients treated in orthopaedic wards, who also 
received more information of pain treatment and used more frequently non-medicine 
methods of pain relief. 
 
Table 1: Rotated component matrix of factor loadings for NRS items for phase 1 data. 
 
 Components 
1 2 3 4 
Pain 
intensity and 
interference 
Affective 
impairment 
Adverse 
effects 
Perceptions 
of care 
Explained variance (total: 60.78%)  36.21% 9.87% 7.62% 7.07% 
Least pain in 24 hours ,716 ,416 ,239 -,198 
Worst pain in 24 hours ,800 ,369 ,352 -,216 
Percentage of time in severe pain ,786 ,411 ,237 -,288 
Pain interference with activities in bed ,775 ,408 ,430 -,136 
Pain interference with activities out of bed ,745 ,421 ,442 -,111 
Pain interference with falling asleep ,804 ,481 ,208 -,158 
Pain interference with staying asleep ,791 ,484 ,223 -,147 
Emotional impairment due to pain: anxious ,493 ,848 ,311 -,143 
Emotional impairment due to pain: depressed ,529 ,777 ,404 -,102 
Emotional impairment due to pain: frightened ,472 ,865 ,312 -,122 
Emotional impairment due to pain: helpless ,419 ,881 ,345 -,092 
Adverse effects: nausea ,270 ,241 ,761 -,036 
Adverse effects: drowsiness ,334 ,309 ,777 -,001 
Adverse effects: itching ,219 ,289 ,438 -,087 
Adverse effects: dizziness ,305 ,350 ,781 -,020 
Percentage of pain relief in 24 hours -,429 -,181 -,019 ,626 
Participation in decision making ,075 ,033 -,017 ,716 
Satisfaction with pain treatment -,363 -,235 -,066 ,778 
Table 2: Cronbach's alpha and item-to-subscale (item-rest) correlations for the 18 NRS item 
for phase 1 data 
Item N Sign  Item-test 
correlation 
Item-rest 
correlation 
Average 
inter-item 
correlation 
Cronbach’s 
Alpha 
Least pain in 24 hours 5104                         + 0.65 0.58    0.29   0.87 
Worst pain in 24 hours 5108 + 0.70              0.65          0.28 0.87 
Percentage of time in severe pain 4948 + 0.69                        0.64 0.28 0.87 
Pain interference with activities in 
bed 
5007 + 0.71 0.65 0.28  0.87 
Pain interference with activities out 
of bed 
4240 + 0.69 0.63 0.28  0.87 
Pain interference with falling asleep 5033 + 0.70 0.65 0.28  0.87 
Pain interference with staying asleep 5002 + 0.70 0.64 0.28  0.87 
Emotional impairment due to pain: 
anxious 
5049 + 0.67 0.61 0.28  0.87 
Emotional impairment due to pain: 
depressed 
5027 + 0.66 0.60 0.28  0.87 
Emotional impairment due to pain: 
frightened 
5029 + 0.64 0.58 0.29 0.87 
Emotional impairment due to pain: 
helpless 
5003 + 0.68 0.62 0.28 0.87 
Adverse effects: nausea 5,097 + 0.45 0.37 0.30 0.88 
Adverse effects: drowsiness 5077 + 0.51 0.43 0.30 0.88 
Adverse effects: itching 5086 + 0.38 0.29 0.31 0.88 
Adverse effects: dizziness 5,078 + 0.51 0.43 0.30 0.88 
Percentage of pain relief in 24 hours 4727 - 0.43 0.34 0.30 0.88 
Participation in decision making 4772 - 0.11 0.01 0.33 0.89 
Satisfaction with pain treatment 4859 - 0.44 0.36 0.30 0.88 
Test scale     0.29 0.88 
 
 
Table 3: Cronbach's alpha and item-to-subscale (item-rest) correlations for the four 
subscales for phase 1 data 
 
Subscale and item N Sign Item-test 
correlation 
Item-rest 
correlation 
Average 
interitem 
correlation 
alpha 
Subscale ‘pain intensity and 
interference’ 
      
Least pain in 24 hours 5104 + 0.73 0.62 0.56 0.88 
Worst pain in 24 hours 5108   + 0.80 0.71 0.53 0.87 
Percentage of time in severe pain 4948 + 0.79 0.79 0.54 0.87 
Pain interference with activities in bed 5007  + 0.78 0.69 0.54 0.87 
Pain interference with activities out of 
bed 
4240 + 0.76 0.66 0.55 0.88 
Pain interference with falling asleep 5033 + 0.81 0.72 0.53 0.87 
Pain interference with staying asleep 5002 + 0.79 0.70 0.54 0.87 
Test scale     0.54 0.89 
Subscale ‘affective impairment’       
Emotional impairment due to pain: 
anxious 
5049 + 0.85 0.72 0.62 0.83 
Emotional impairment due to pain: 
depressed 
5027 + 0.86 0.74 0.61 0.82 
Emotional impairment due to pain: 
frightened 
5029 + 0.87 0.76 0.60 0.82 
Emotional impairment due to pain: 
helpless 
5003 + 0.81 0.66 .066 0.86 
Test scale     0.62 0.87 
Subscale ‘adverse effects’       
Adverse effects: nausea 5,097 + 0.73 0.49 0.31 0.58 
Adverse effects: drowsiness 5077 + 0.74 0.50 0.30 0.57 
Adverse effects: itching 5086 + 0.59 0.28 0.45 0.71 
Adverse effects: dizziness 5,078 + 0.77 0.55 0.28 0.53 
Test scale     0.34 0.67 
Subscale ‘perceptions of care’       
Percentage of pain relief in 24 hours 4727 + 0.72 0.33 0.27 0.43 
Participation in decision making 4772 + 0.66 0.23 0.41 0.58 
Satisfaction with pain treatment 4859 + 0.79 0.43 0.12 0.22 
Test scale     0.27 0.52 
 
Table 4: Significant mean differences of 18 items for type of surgery (general surgery versus 
orthopaedics surgery) for phase 1 data  
 
NRS item N  
General 
surgery 
Mean  
General 
surgery 
N  
Orthopaedics 
surgery 
Mean 
Orthopaedics 
surgery 
p value 
Mann-
Whitney 
U test 
Least pain in 24 hours 2,324 2.22/ 2,456 2.59 <0.001 
Worst pain in 24 hours 2,322 5.01 2,464 6.07 <0.001 
Percentage of time in severe pain 2,255 2.22 2,374 3.31 <0.001 
Pain interference with activities in bed 2,287 4.24 2,401 4.89 <0.001 
Pain interference with activities out of 
bed 
2,094 3.61 1,876 4.89 <0.001 
Pain interference with falling asleep 2,296 2.51 2,418 3.60 <0.001 
Pain interference with staying asleep 2,283 2.60 2,402 3.72 <0.001 
Emotional impairment due to pain: 
anxious 
2,301 2.38 2,428 2.52 0.112 
Emotional impairment due to pain: 
depressed 
2,292 1.68 2,416 1.98 0.001 
Emotional impairment due to pain: 
frightened 
2,294 1.73 2,416 1.74 0.457 
Emotional impairment due to pain: 
helpless 
2,283 1.85 2,402 2.50 <0.001 
Adverse effects: nausea 2,326 1.95 2,450 1.93 0.497 
Adverse effects: drowsiness 2,314 3.12 2,444 3.06 0.408 
Adverse effects: itching 2,316 0.55 2,449 0.69 0.007 
Adverse effects: dizziness 2,322 1.95 2,437 1.69 <0.001 
Percentage of pain relief in 24 hours 2,135 6.87 2,285 6.45 <0.001 
Participation in decision making 2,167 5.31 2297 5.90 <0.001 
Satisfaction with pain treatment 2,204 8.58 2,338 8.01 <0.001 
Binary item N  
General 
Surgery 
% ‘yes’  
General 
surgery 
N 
Orthopaedics 
surgery 
% ‘yes’  
Orthopaedics 
surgery 
p value 
Chi
2
 test 
Information on pain treatment options 
received 
2,290 57.16 2,432 63.86 <0.001 
Use of non-medicine methods for pain 
relief 
2,300 31.65 2,452 44.45 <0.001 
 
 
Supplemental Information 3: Item list of the International Pain Outcomes questionnaire 
(IPO) 
 
Item Answer format 
P1. On this scale, please indicate the worst pain you had since your surgery: NRS 0-10 
P2. On this scale, please indicate the least pain you had since your surgery: NRS 0-10 
P3. How often were you in severe pain since your surgery? 
Please circle your best estimate of the percentage of time you experienced 
severe pain: 
NRS 0-100% 
P4. Circle the one number below that best describes how much, since your 
surgery, pain interfered with or prevented you from ... 
 
a. doing activities in bed such as turning, sitting up, changing position NRS 0-10 
b. breathing deeply or coughing NRS 0-10 
c. sleeping NRS 0-10 
d. Have you been out of bed since your surgery? yes/no 
If yes, how much did pain interfere or prevent you from doing activities out 
of bed such as walking, sitting in a chair, standing at the sink: 
NRS 0-10 
P5. Pain can affect our mood and emotions. 
On this scale, please circle the one number that best shows how much, since 
your surgery, 
pain caused you to feel ... 
 
a. anxious NRS 0-10 
b. helpless NRS 0-10 
P6. Have you had any of the following side effects since your surgery? 
Please circle “0” if no; if yes, circle the one number that best shows the severity 
of each: 
 
a. Nausea NRS 0-10 
b. Drowsiness NRS 0-10 
c. Itching NRS 0-10 
d. Dizziness NRS 0-10 
Tables
P7. Since your surgery, how much pain relief have you received? 
Please circle the one percentage that best shows how much relief you have 
received from all of your pain treatments combined (medicine and non-
medicine treatments): 
NRS 0-100% 
P8. Would you have liked MORE pain treatment than you received? yes/no 
P9. Did you receive any information about your pain treatment options? yes/no 
P10. Were you allowed to participate in decisions about your pain treatment 
as much as you wanted to? 
NRS 0-10 
P11. Circle the one number that best shows how satisfied you are with the 
results of your pain treatment since your surgery: 
NRS 0-10 
P12. Did you use or receive any non-medicine methods to relieve your pain? yes/no 
If yes, check all that apply: 
cold pack, meditation, deep breathing, heat, acupuncture, prayer, talking to 
medical staff, walking, massage, talking to friends or relatives, relaxation, 
imagery or visualization, TENS (Transcutaneous Electrical Nerve Stimulation), 
distraction (like watching TV, listening to music, reading), other (please 
describe) 
 
P13. Did you have a persistent painful condition for 3 months or more 
before coming into hospital for this surgery? 
yes/no 
a. If yes, how severe was the pain most of the time? 
Please circle the number that indicates this. 
NRS 0-10 
b. If yes, where was this persistent pain located? 
Site of surgery, elsewhere, both (site of surgery and elsewhere) 
 
 
 
